These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22707061)

  • 1. Dairy foods and osteoporosis: an example of assessing the health-economic impact of food products.
    Lötters FJ; Lenoir-Wijnkoop I; Fardellone P; Rizzoli R; Rocher E; Poley MJ
    Osteoporos Int; 2013 Jan; 24(1):139-50. PubMed ID: 22707061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France.
    Hiligsmann M; Burlet N; Fardellone P; Al-Daghri N; Reginster JY
    Osteoporos Int; 2017 Mar; 28(3):833-840. PubMed ID: 27757506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The projected public health and economic impact of vitamin D fortified dairy products for fracture prevention in France.
    Hiligsmann M; Reginster JY
    Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):191-195. PubMed ID: 28862051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future economic burden of osteoporosis in New Zealand.
    Brown P; McNeill R; Leung W; Radwan E; Willingale J
    Appl Health Econ Health Policy; 2011 Mar; 9(2):111-23. PubMed ID: 21271750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effective osteoporosis treatment thresholds in Greece.
    Makras P; Athanasakis K; Boubouchairopoulou N; Rizou S; Anastasilakis AD; Kyriopoulos J; Lyritis GP
    Osteoporos Int; 2015 Jul; 26(7):1949-57. PubMed ID: 25740208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The health burden and costs of incident fractures attributable to osteoporosis from 2010 to 2050 in Germany--a demographic simulation model.
    Bleibler F; Konnopka A; Benzinger P; Rapp K; König HH
    Osteoporos Int; 2013 Mar; 24(3):835-47. PubMed ID: 22797490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Majumdar SR; Lier DA; Hanley DA; Juby AG; Beaupre LA;
    Osteoporos Int; 2017 Jun; 28(6):1965-1977. PubMed ID: 28275838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.
    Su Y; Lai FTT; Yip BHK; Leung JCS; Kwok TCY
    Osteoporos Int; 2018 Aug; 29(8):1793-1805. PubMed ID: 29774400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: a Markov micro-simulation model applied to the French population over 65 years old without previous hip fracture.
    Zarca K; Durand-Zaleski I; Roux C; Souberbielle JC; Schott AM; Thomas T; Fardellone P; Benhamou CL
    Osteoporos Int; 2014 Jun; 25(6):1797-806. PubMed ID: 24691648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures.
    Ethgen O; Hiligsmann M; Burlet N; Reginster JY
    Osteoporos Int; 2016 Jan; 27(1):301-8. PubMed ID: 26395885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Moriwaki K; Noto S
    Osteoporos Int; 2017 Feb; 28(2):621-632. PubMed ID: 27699441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milk and other dairy foods and risk of hip fracture in men and women.
    Feskanich D; Meyer HE; Fung TT; Bischoff-Ferrari HA; Willett WC
    Osteoporos Int; 2018 Feb; 29(2):385-396. PubMed ID: 29075804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality.
    Marques A; Lourenço Ó; da Silva JA;
    Osteoporos Int; 2015 Nov; 26(11):2623-30. PubMed ID: 25986386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The societal burden of osteoporosis in Sweden.
    Borgström F; Sobocki P; Ström O; Jönsson B
    Bone; 2007 Jun; 40(6):1602-9. PubMed ID: 17433804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessment of osteoporosis-related femoral fractures and economic burden in Saudi Arabia.
    Sadat-Ali M; Al-Dakheel DA; Azam MQ; Al-Bluwi MT; Al-Farhan MF; AlAmer HA; Al-Meer Z; Al-Mohimeed A; Tabash IK; Karry MO; Rassasy YM; Baragaba MA; Amer AS; AlJawder A; Al-Bouri KM; ElTinay M; Badawi HA; Al-Othman AA; Tayara BK; Al-Faraidy MH; Amin AH
    Arch Osteoporos; 2015; 10():37. PubMed ID: 26494131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dietary sources of calcium and protein on hip fractures and falls in older adults in residential care: cluster randomised controlled trial.
    Iuliano S; Poon S; Robbins J; Bui M; Wang X; De Groot L; Van Loan M; Zadeh AG; Nguyen T; Seeman E
    BMJ; 2021 Oct; 375():n2364. PubMed ID: 34670754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options.
    Chandran M; Lau TC; Gagnon-Arpin I; Dobrescu A; Li W; Leung MYM; Patil N; Zhao Z
    Arch Osteoporos; 2019 Nov; 14(1):114. PubMed ID: 31773442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A health economic simulation model for the clinical management of osteoporosis.
    Jonsson E; Hansson-Hedblom A; Ljunggren Ö; Åkesson K; Spångeus A; Kanis JA; Borgström F
    Osteoporos Int; 2018 Mar; 29(3):545-555. PubMed ID: 29196775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
    Hernlund E; Svedbom A; Ivergård M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jönsson B; Kanis JA
    Arch Osteoporos; 2013; 8(1):136. PubMed ID: 24113837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and Future Incidence and Costs of Osteoporosis-Related Fractures in The Netherlands: Combining Claims Data with BMD Measurements.
    Lötters FJ; van den Bergh JP; de Vries F; Rutten-van Mölken MP
    Calcif Tissue Int; 2016 Mar; 98(3):235-43. PubMed ID: 26746477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.